explore -WSS

explore

author：knowledge 2025-10-01 06:01:47 - browse：1965

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： 5 dead in mass shooting on Caribbean island of St. Vincent: Police

leisure time

WSS

Hormonal contraceptives don’t actually treat endometriosis

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Belarusian journalist sentenced to 4 years in prison as crackdown continues

GOP inquiry over gain

Mystery swirls around US soldier who entered North Korea days ago, officials say

Brazil's Jair Bolsonaro is barred from running for office until 2030

hotspot

explore

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

ADA: All diabetes patients should be screened for liver condition

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Medicare details structure of new drug price negotiation program

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Walensky prepares to leave CDC — and Congress — behind

Here's how to stay safe from wildfire smoke amid reduced air quality

Walensky prepares to leave CDC — and Congress — behind

Eating disorder hotline's move to chatbot carried cost for volunteers

knowledge

How a Boston hospital is priming medical residents to use GPT

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Caribou posts encouraging results on off

Brazil's Jair Bolsonaro is barred from running for office until 2030

There’s a way to spot data fakery. All journals should be using it

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

knowledge

entertainment

leisure time

hotspot